Real-Time Quantitative PCR Analysis of Regions Involved in Gene Amplification Reveals Gene Overdose in Low-Grade Astrocytic Gliomas

We have studied gene amplification of genes located in 1q32 (GAC1, ELF3, MDM4, and ren1), 4q11 (PDGFR-α), and in 12q13-14 (MDM2 and CDK4) using quantitative real-time PCR in a group of 86 tumors consisting of 44 WHO grade IV glioblastomas (GBM) (34 primary and 10 secondary tumors), 21 WHO grade III anaplastic astrocytomas (AA), and 21 WHO grade II astrocytomas (AII). Gene amplification was present in 56 of the 86 samples (65%) in at least 1 gene in our series. GAC1 (51%) and MDM4 (27%) were the most frequently amplified genes within the 1q32 amplicon, and their higher amplification frequency was statistically significant (P < 0.05, χ2) in the low-grade astrocytomas. Concordant coamplification was determined for ELF3 and ren1 or ren1 and MDM4 in the grade III-IV tumors. MDM2 amplification was significantly more frequent in primary GBM (16%) than was in secondary GBM (0%). The present study shows that gene amplification in the studied regions is already present in low-grade astrocytic tumors and that amplification of some genes may represent another molecular marker to differentiate primary from secondary GBM.

[1]  M. Alonso,et al.  Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative‐PCR analysis of non‐homogeneous gene amplification and DNA sequence alterations , 2005, Neuropathology and applied neurobiology.

[2]  M. Alonso,et al.  Real-time quantitative PCR analysis of gene dosages reveals gene amplification in low-grade oligodendrogliomas. , 2005, American journal of clinical pathology.

[3]  M. Alonso,et al.  Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors. , 2004, Mutation research.

[4]  R. Janzer,et al.  Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma , 2004, British Journal of Cancer.

[5]  Jeremy R Stuart,et al.  DNA Damage-induced MDMX Degradation Is Mediated by MDM2* , 2003, Journal of Biological Chemistry.

[6]  G. Reifenberger,et al.  Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target , 2003, International journal of cancer.

[7]  M. Alonso,et al.  Promoter hypermethylation of multiple genes in astrocytic gliomas. , 2003, International journal of oncology.

[8]  N. Tsuji,et al.  Selection of an internal control gene for quantitation of mRNA in colonic tissues. , 2002, Anticancer research.

[9]  A. Greene,et al.  Microvascular angiogenesis and the renin-angiotensin system , 2002, Current hypertension reports.

[10]  G. Fuller.  Pathology and Genetics of Tumours of the Nervous System (World Health Organization Classification of Tumours). , 2001 .

[11]  O. Berthier‐Vergnes,et al.  Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. , 2001, Analytical biochemistry.

[12]  C. James,et al.  Amplification of the Platelet‐Derived Growth Factor Receptor‐A (PDGFRA) Gene Occurs in Oligodendrogliomas with Grade IV Anaplastic Features , 2000, Journal of neuropathology and experimental neurology.

[13]  K. Ichimura,et al.  Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. , 2000, Cancer research.

[14]  M. Wolter,et al.  Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. , 1999, Cancer research.

[15]  T. Libermann,et al.  Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter. , 1999, Genomics.

[16]  J. Niland,et al.  The MDM2 gene amplification database. , 1998, Nucleic acids research.

[17]  S. Hanash,et al.  GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas , 1998, Oncogene.

[18]  P. Steinert,et al.  The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. , 1997, Nucleic acids research.

[19]  T. Libermann,et al.  The novel epithelial-specific Ets transcription factor gene ESX maps to human chromosome 1q32.1. , 1997, Genomics.

[20]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[21]  Wen-Lin Kuo,et al.  ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis , 1997, Oncogene.

[22]  Y. Yonekawa,et al.  Amplification and Overexpression of MDM2 in Primary (de novo) Glioblastomas , 1997, Journal of neuropathology and experimental neurology.

[23]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[24]  P. Meltzer,et al.  Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. , 1996, Cancer research.

[25]  A. Jochemsen,et al.  MDMX: a novel p53‐binding protein with some functional properties of MDM2. , 1996, The EMBO journal.

[26]  D. Louis,et al.  Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme , 1996, Acta Neuropathologica.

[27]  V. Collins.  Gene amplification in human gliomas , 1995, Glia.

[28]  C. Heldin,et al.  Platelet‐derived growth factor in human glioma , 1995, Glia.

[29]  A. Guha,et al.  Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop , 1995, International journal of cancer.

[30]  C. James,et al.  CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. , 1994, Cancer research.

[31]  P. Meltzer,et al.  Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. , 1994, Cancer research.

[32]  A. Nordheim,et al.  Gene regulation by Ets proteins. , 1993, Biochimica et biophysica acta.

[33]  D. Lane,et al.  What the papers say: The p53‐mdm2 autoregulatory feedback loop: A paradigm for the regulation of growth control by p53? , 1993 .

[34]  C. D. James,et al.  Gene and chromosomal alterations associated with the development of human gliomas , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  J. Rey,et al.  Loss of heterozygosity for distal markers on 22q in human gliomas , 1992, International journal of cancer.

[36]  E. Manuelidis,et al.  Renin in glioblastoma multiforme and its role in neovascularization. , 1988, American Journal of Clinical Pathology.

[37]  D. Louis,et al.  Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. , 1996, Cancer research.

[38]  D. Demetrick,et al.  Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes. , 1994, Cytogenetics and cell genetics.

[39]  V. Tenedieva,et al.  The CSF aldosterone in brain tumors with brain edema. , 1994, Acta neurochirurgica. Supplementum.